BONFANTI, PAOLO
BONFANTI, PAOLO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Efficacy and tolerability of pravastatin for short-term management of primary hypercholesterolaemia [EFFICACIA E TOLLERABILITA DELLA PRAVASTATINA NEL TRATTAMENTO A BREVE TERMINE DELLE IPERCOLESTEROLEMIE PRIMARIE]
1994 Marnini, P; Bonfanti, P; Piantanida, E; Venco, A
Employment of recombinant human granulocyte-macrophage colony stimulating factor in oesophageal candidiasis in AIDS patients [2]
1995 Capetti, A; Bonfanti, P; Magni, C; Milazzo, F
Desensitization to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus [4]
1996 Quirino, T; Bonfanti, P; Niero, F; Rizzardini, G; Iemoli, E; Milazzo, F; Ruskin, J; Gluckstein, D
Hypersensitivity reactions during antiretroviral regimens with protease inhibitors [8]
1997 Bonfanti, P; Capetti, A; Riva, P; Testa, L; Quirino, T
Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients
1998 Bonfanti, P; Capetti, A; Di Mattei, P; Niero, F; Rizzardini, G
Acetylator phenotype prevalence in HIV-infected patients without previous trimethoprim-sulfamethoxazole hypersensitivity
1999 Quirino, T; Bonfanti, P; Arcidiacono, M; Pusterla, L; Cagni, A; Scaglione, F; Milazzo, F
HIV disease treatment in the era of HAART
1999 Bonfanti, P; Capetti, A; Rizzardini, G
Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study
2000 Bonfanti, P; Valsecchi, L; Parazzini, F; Carradori, S; Pusterla, L; Fortuna, P; Timillero, L; Alessi, F; Ghiselli, G; Gabbuti, A; Di Cintio, E; Martinelli, C; Faggion, I; Landonio, S; Quirino, T
Cause and effect relationship of drug adverse events: Our experience using protease inhibitors of HIV [Relazione di causalità delle reazioni avverse a farmaci: Un'esperienza nell'utilizzo degli inibitori della proteasi di HIV]
2000 Bonfanti, P; Valsecchi, L; Parazzini, F; Carradori, S; Pusterla, L; Fortuna, P; Timillero, L; Alessi, F; Ghiselli, G; Gabbuti, A; Ricci, E; Martinelli, C; Faggion, I; Landonio, S; Quirino, T
Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase [3]
2000 Bonfanti, P; Faggion, I; La Seta Catamancio, S; Violin, M; Balotta, C; Rusconi, S
The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: A randomized multicentric study
2000 Bonfanti, P; Pusterla, L; Parazzini, F; Libanore, M; Cagni, A; Franzetti, M; Faggion, I; Landonio, S; Quirino, T
HAART tolerability: post-exposure prophylaxis in healthcare workers versus treatment in HIV-infected patients
2000 Quirino, T; Niero, F; Ricci, E; Pusterla, L; Carradori, S; Gabbuti, A; Iemoli, E; Landonio, S; Faggion, I; Bonfanti, P
Osteonecrosis in protease inhibitor-treated patients
2001 Bonfanti, P; Grabbuti, A; Carradori, S; Pusterla, L; Parrazini, F; Landonio, S; Quirino, T
Predictors of protease inhibitor-associated adverse events
2001 Bonfanti, P; Ricci, E; Landonio, S; Valsecchi, L; Timillero, L; Faggion, I; Quirino, T
Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy
2001 Bonfanti, P; Landonio, S; Ricci, E; Martinelli, C; Fortuna, P; Faggion, I; Quirino, T
Bilateral carotid stenosis in a young female HIV patient treated with highly active antiretroviral therapy
2002 Landonio, S; Quirino, T; Pelucchi, A; Magni, C; Coen, M; Porretta, T; Faggion, I; Bonfanti, P; Vigevani, G
Risk factors for lipodystrophy in the CISAI cohort
2003 Bonfanti, P; Gulisano, C; Ricci, E; Timillero, L; Valsecchi, L; Carradori, S; Pusterla, L; Fortuna, P; Miccolis, S; Magnani, C; Gabbuti, A; Parazzini, F; Martinelli, C; Faggion, I; Landonio, S; Quirino, T; Vigevani, G
Hypothyroidism in HIV-infected patients who have or have not received HAART
2004 Quirino, T; Bongiovanni, M; Ricci, E; Chebat, E; Carradori, S; Martinelli, C; Valsecchi, L; Landonio, S; Bini, T; Bonfanti, P
Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART
2004 Landonio, S; Quirino, T; Bonfanti, P; Gabris, A; Boccassini, L; Gulisano, C; Vulpio, L; Ricci, E; Carrabba, M; Vigevani, G
Antiretroviral therapy in chronic liver disease: focus on HIV/HCV coinfection--statements of the First Italian Consensus Workshop
2005 Carosi, G; Puoti, M; Antonucci, G; De Luca, A; Maserati, R; Torti, C; Bonfanti, P; Bonora, S; Bruno, R; Gaeta, G; Antinori, A; Monforte, A; Orani, A; Sagnelli, E; Cargnel, A; Cauda, R; Mazzotta, F; Pastore, G; Suter, F; Vullo, V